What is Opus Genetics's interest coverage?

Opus Genetics (IRD) reported interest coverage of -217.3× in Q1 2026.

What is the long-term trend for Opus Genetics's interest coverage?

Over 3 years (2020 to 2025), Opus Genetics's interest coverage has grown at a 368.1% compound annual growth rate (CAGR), from -2.9× to -299.2×.

What does interest coverage mean?

Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.

Opus Genetics IRD Interest coverage

Interest coverage at other companies

MeiraGTx Holdings plcMGTX

-13.1×-0.2×

Opko HealthOPK

-1×-0.4×

Kodiak Sciences IncKOD

-42,382.4×-296,817×

Regeneron PharmaceuticalsREGN

75.6×-4.5×

RegenxbioRGNX

-5.7×-1.3×

Candel Therapeutics, Inc.CADL

-16.7×-1.9×

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

ebit/interest expense=-217.3×

Based on trailing twelve months.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's interest coverage?: Opus Genetics (IRD) reported interest coverage of -217.3× in Q1 2026.
What is the long-term trend for Opus Genetics's interest coverage?: Over 3 years (2020 to 2025), Opus Genetics's interest coverage has grown at a 368.1% compound annual growth rate (CAGR), from -2.9× to -299.2×.
What does interest coverage mean?: Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.